About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:6200082
Allelic
Composition
Patl2tm1b(EUCOMM)Hmgu/Patl2tm1b(EUCOMM)Hmgu
Genetic
Background
involves: C57BL/6N * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Patl2tm1b(EUCOMM)Hmgu mutation (0 available); any Patl2 mutation (32 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
reproductive system
N
• male fertility is normal
• increase in the number of primordial oocytes at P26 but not at P12 compared to wild-type controls
• numbers of primary and secondary follicles are similar at P12 and P26
• significant increase in the number of MII oocytes with abnormal spindle morphology, misalignment of chromosomes on the spindle and numerous cytoplasmic asters
• oocyte growth is impaired
• increase in the percentage of oocytes released at stages before MII, 45% compared to 26% in wild-type controls
• following pregnant mare serum gonadotropin ovarian stimulation, germinal vesicle oocytes are smaller in diameter compared to similarly treated wild-type controls
• however, the number of oocytes produced by stimulation is similar to controls
• unlike human patients, stimulated mice produce MII stage oocytes but these are also smaller in diameter compared to controls
• oocyte meiotic maturation is impaired
• significant increase in the number of MII oocytes with abnormal spindle morphology, misalignment of chromosomes on the spindle and numerous cytoplasmic asters
• oocytes apparently arrested at MI display misaligned chromosomes and abundant cytoplasmic asters
• severe reduction with both total number of pups and litters per month reduced over a 6 month period when crossed to wild-type males
• fertilized zygotes show numerous defects, including delayed pronucleus formation, absence of sperm DNA decondensation, and/or polyspermy
• only 27.2% +/- 5.1 of 2-cell embryos reach the blastocyst stage compared to 87.1% +/- 5.6% for wild-type controls
• average litter size is 2.3 +/- 0.4 compared to 7.3 +/- 0.8 for wild-type controls when both are crossed to wild-type males
• fertilized zygotes show numerous defects, including polyspermy
• decrease in the percentage of eggs reaching the 2-cell stage following IVF to 36.4% +/- 6.4%, estimated to be a 65% success rate for MII stage oocytes compared to 90% for wild-type controls

cellular
• following pregnant mare serum gonadotropin ovarian stimulation, germinal vesicle oocytes are smaller in diameter compared to similarly treated wild-type controls
• however, the number of oocytes produced by stimulation is similar to controls
• unlike human patients, stimulated mice produce MII stage oocytes but these are also smaller in diameter compared to controls

endocrine/exocrine glands
• increase in the number of primordial oocytes at P26 but not at P12 compared to wild-type controls
• numbers of primary and secondary follicles are similar at P12 and P26

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
ovarian disease DOID:1100 J:264835


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/09/2024
MGI 6.23
The Jackson Laboratory